Study title: Yurdakul S., Cem Mat, Yalçin Tüzün, Ylmaz Ozyazgan, Vedat Hamuryudan, Omer Uysal, Mustafa Senocak and Hasan Yazici. A Double-Blind Trial of Colchicine in Behçet’s Syndrome. 2001; 44,11: 2686-2692Yurdakul S., Cem Mat, Yalçin Tüzün, Ylmaz Ozyazgan, Vedat Hamuryudan, Omer Uysal, Mustafa Senocak and Hasan Yazici. A Double-Blind Trial of Colchicine in Behçet’s Syndrome. 2001; 44,11: 2686-2692
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Stomatognathic Diseases [C07] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: COLCHICINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |